Acute Effects of Nebulized Salbutamol on Resting Energy Expenditure in Patients with Chronic Obstructive Pulmonary Disease and in Healthy Subjects

This study investigated the contribution of a single dose of salbutamol by nebulizer to the increased resting energy expenditure (REE) frequently found in patients with chronic obstructive pulmonary disease (COPD) (n = 22), in comparison with a younger (n = 15) and an older healthy (n = 10) control group. The rise in REE after nebulization of 5 mg salbutamol was significantly higher in younger (11.4%) compared to older healthy subjects (5.7%; p < 0.05) and patients with COPD (4.2%; p < 0.001), which also accounted for the increase in heart rate and the drop in the respiratory quotient. No differences in metabolic effects were found between older control subjects and patients with COPD. In conclusion, despite significant improvements in FEV1 and airway resistance, a significant rise in REE was observed in patients with COPD after nebulization of salbutamol. The metabolic effects of salbutamol were however not sufficient to explain totally the elevated REE seen in these patients.

[1]  E. Wouters,et al.  Effects of an acute exacerbation on nutritional and metabolic profile of patients with COPD. , 1997, The European respiratory journal.

[2]  Y. Schutz,et al.  Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease. , 1997, Thorax.

[3]  E. Wouters,et al.  Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. , 1996, Thorax.

[4]  J. Ramsdell,et al.  The effects of theophylline on metabolic rate in chronic obstructive lung disease patients. , 1996, Journal of the American College of Nutrition.

[5]  Y. Schutz,et al.  The daily energy expenditure in stable chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.

[6]  J. Mege,et al.  Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. , 1994, American journal of respiratory and critical care medicine.

[7]  J. Moxham,et al.  Effect of oral theophylline on resting energy expenditure in normal volunteers. , 1994, Thorax.

[8]  M. Lean,et al.  Resting energy expenditure and nutritional state of patients with increased oxygen cost of breathing due to emphysema, scoliosis and thoracoplasty. , 1994, Thorax.

[9]  S. R. Wilson,et al.  Acute effects of inhaled salbutamol on the metabolic rate of normal subjects. , 1993, Thorax.

[10]  A. Tattersfield,et al.  Beta agonists and ventilation. , 1993, Thorax.

[11]  S. R. Wilson,et al.  Modification of the thermogenic effect of acutely inhaled salbutamol by chronic inhalation in normal subjects. , 1993, Thorax.

[12]  E. Wouters,et al.  Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. , 1993, The American review of respiratory disease.

[13]  G. Gibson.  Standardised lung function testing. , 1993, The European respiratory journal.

[14]  K R Westerterp,et al.  Resting energy expenditure in patients with chronic obstructive pulmonary disease. , 1991, The American journal of clinical nutrition.

[15]  K. Westerterp,et al.  Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. , 1991, The American journal of clinical nutrition.

[16]  P. Deurenberg,et al.  Sex and age specific prediction formulas for estimating body composition from bioelectrical impedance: a cross-validation study. , 1991, International journal of obesity.

[17]  B. Lipworth,et al.  Beta-adrenoceptor responses to inhaled salbutamol in the elderly. , 1989, British journal of clinical pharmacology.

[18]  R. Rogers,et al.  Oxygen consumption of the respiratory muscles in normal and in malnourished patients with chronic obstructive pulmonary disease. , 1989, The American review of respiratory disease.

[19]  N. Anthonisen,et al.  Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. , 1989, The American review of respiratory disease.

[20]  E. Fiaccadori,et al.  Hypercapnic-hypoxemic chronic obstructive pulmonary disease (COPD): influence of severity of COPD on nutritional status. , 1988, American Journal of Clinical Nutrition.

[21]  A. Hjalmarson,et al.  Age and sex differences in cardiovascular reactivity to adrenergic agonists, mental stress and isometric exercise in normal subjects. , 1988, Scandinavian journal of clinical and laboratory investigation.

[22]  I. Macdonald,et al.  The effect of adrenaline upon cardiovascular and metabolic functions in man. , 1985, Clinical science.

[23]  M. Gardner,et al.  Statistical guidelines for contributors to medical journals. , 1983, British medical journal.

[24]  S. Holgate,et al.  Airway and metabolic resistance to intravenous salbutamol: a study in normal man. , 1980, Clinical science.

[25]  B. Waldeck,et al.  Effects of beta-adrenoceptor agonists on airway smooth muscle and on slow-contracting skeletal muscle: in vitro and in vivo results compared. , 2009, Acta pharmacologica et toxicologica.

[26]  β-ADRENORECEPTOR AGONISTS , 1976 .

[27]  J. B. Weir.  New methods for calculating metabolic rate with special reference to protein metabolism , 1949, The Journal of physiology.